Share Price | Rallybio Corp. Stock Analysis & Recommendation

Q: Is Rallybio Corp. technically bullish or bearish?

As of 8 September 2025, the technical trend for Rallybio Corp. has changed from sideways to mildly bearish. The current stance is bearish, primarily driven by the daily moving averages indicating a mildly bearish position and the weekly RSI showing bearish momentum. Although the weekly MACD and Bollinger Bands suggest mild bullishness, they are overshadowed by the overall bearish signals from the daily indicators. The stock has underperformed significantly against the S&P 500, with a year-to-date return of -37.58% compared to the S&P 500's 12.22%.

Q: What does Rallybio Corp. do?

Overview: Rallybio Corp. operates in the miscellaneous industry and is classified as a micro-cap company.Financial Snapshot: Most recent Net Sales: 0 Million (Quarterly Results - Mar 2025) Most recent Net Profit: -9 Million (Quarterly Results - Mar 2025) Market cap: USD 14.07 Million (Micro Cap)Key Metrics: P/E: NA (Loss Making) Industry P/E: NA Dividend Yield: 0.00% Debt Equity: -1.01 Return on Equity: -89.11% Price to Book: 0.26Contact Details: Details: No Company Details Available Registrar Address: Not available.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

16.82 k

Shareholding (Mar 2026)

FII

3.11%

Held by 22 FIIs

DII

57.05%

Held by 23 DIIs

Promoter

39.84%

Is Rallybio Corp. technically bullish or bearish?

20-Sep-2025

As of September 8, 2025, Rallybio Corp. is in a mildly bearish trend, with daily moving averages and weekly RSI indicating bearish momentum, despite some mild bullish signals from the MACD and Bollinger Bands, and it has underperformed the S&P 500 with a year-to-date return of -37.58%.

View full answer

How big is Rallybio Corp.?

22-Jun-2025

As of Jun 18, Rallybio Corp. has a market capitalization of 14.07 million, with net sales of 0.85 million and a net loss of 48.19 million over the latest four quarters. Shareholder's funds are 61.65 million, and total assets amount to 68.11 million.

View full answer

What does Rallybio Corp. do?

22-Jun-2025

Rallybio Corp. is a micro-cap company in the miscellaneous industry, reporting net sales of $0 million and a net loss of $9 million as of March 2025, with a market cap of $14.07 million. Key metrics include a negative P/E ratio, a 0.00% dividend yield, and a return on equity of -89.11%.

View full answer

Compare Rallybio Corp. with Similar Stocks

Absci Corp.Startek, Inc.VCI Global Ltd.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Stock DNA

Industry

Miscellaneous

Market cap

USD 43 Million (Micro Cap)

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.94

Return on Equity

-9.62%

Price to Book

0.75

Revenue and Profits:

Net Sales:

0 Million

(Quarterly Results - Mar 2026)

Net Profit:

-8 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

70.62%

6 Months

156.65%

1 Year

512.16%

2 Years

42.59%

3 Years

-73.59%

4 Years

-72.27%

5 Years

0.0%

Rallybio Corp. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

13.21%

EBIT Growth (5y)

-3.71%

EBIT to Interest (avg)

-53.42

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-1.01

Sales to Capital Employed (avg)

0.01

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

76.92%

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

0.75

EV to EBIT

0.38

EV to EBITDA

0.38

EV to Capital Employed

-3.37

EV to Sales

-11.16

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

-9.62%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Mildly Bullish

Dow Theory

No Trend

OBV

Mildly Bearish

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Mar 2026

Shareholding Compare (%holding)

Majority shareholders

Strategic Entities

Domestic Funds

Held in 13 Schemes (22.75%)

Foreign Institutions

Held by 22 Foreign Institutions (3.11%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 0.00% vs 0.00% in Mar 2025",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 11.70% vs 50.53% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.20",
          "val2": "0.20",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-4.70",
          "val2": "-9.60",
          "chgp": "51.04%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-4.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-8.30",
          "val2": "-9.40",
          "chgp": "11.70%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-22,325.50%",
          "val2": "-45,613.20%",
          "chgp": "2,328.77%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 50.00% vs 0.00% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 84.43% vs 22.52% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.90",
          "val2": "0.60",
          "chgp": "50.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-28.00",
          "val2": "-60.40",
          "chgp": "53.64%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-5.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-9.00",
          "val2": "-57.80",
          "chgp": "84.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-32,708.60%",
          "val2": "-95,119.50%",
          "chgp": "6,241.09%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

0.20

Operating Profit (PBDIT) excl Other Income

-4.70

-9.60

51.04%

Interest

0.00

Exceptional Items

-4.00

0.00

Consolidate Net Profit

-8.30

-9.40

11.70%

Operating Profit Margin (Excl OI)

-22,325.50%

-45,613.20%

2,328.77%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is 0.00% vs 0.00% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is 11.70% vs 50.53% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

0.90

0.60

50.00%

Operating Profit (PBDIT) excl Other Income

-28.00

-60.40

53.64%

Interest

0.00

Exceptional Items

-5.00

0.00

Consolidate Net Profit

-9.00

-57.80

84.43%

Operating Profit Margin (Excl OI)

-32,708.60%

-95,119.50%

6,241.09%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 50.00% vs 0.00% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 84.43% vs 22.52% in Dec 2024

All Annual Results

Company CV

About Rallybio Corp.

Rallybio Corp.

Miscellaneous

No Details Available.

Company Coordinates

No Company Details Available